Related references
Note: Only part of the references are listed.Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients
C. B. Cunio et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study
David W. Uster et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotic
Sebastian G. Wicha et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2020)
External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients
Tingjie Guo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting
A. Broeker et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults
Didi Bury et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Application of Pharmacometrics in Pharmacotherapy: Open-Source Software for Vancomycin Therapeutic Drug Management
Soo Hyeon Bae et al.
PHARMACEUTICS (2019)
Augmented Renal Clearance of Vancomycin in Hematologic Malignancy Patients
Tomohiro Izumisawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations
Pieter J. Colin et al.
CLINICAL PHARMACOKINETICS (2019)
Investigation of the age dependency of vancomycin clearance by population pharmacokinetic modeling
Muhammad Usman et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)
Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation
Akira Okada et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Hospitalized Patients With and Without Hemodialysis Have Markedly Different Vancomycin Pharmacokinetics: A Population Pharmacokinetic Model-Based Analysis
Vineet Goti et al.
THERAPEUTIC DRUG MONITORING (2018)
Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing
Michael N. Neely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Influences of renal function descriptors on population pharmacokinetic modeling of vancomycin in Chinese adult patients
Xi-wei Ji et al.
ACTA PHARMACOLOGICA SINICA (2018)
Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration
Xingang Li et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients
Susanna Edith Medellin-Garibay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens
Wei-wei Lin et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Pharmacokinetics of vancomycin and dosing recommendations for trauma patients
Susanna E. Medellin-Garibay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Assessing Predictive Performance of Published Population Pharmacokinetic Models of Intravenous Tobramycin in Pediatric Patients
Celeste Bloomfield et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
TDMx: A novel web-based open-access support tool for optimising antimicrobial dosing regimens in clinical routine
Sebastian G. Wicha et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion
M. F. Waineo et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2015)
Pharmacokinetics of Vancomycin in Extremely Obese Patients with Suspected or Confirmed Staphylococcus aureus Infections
Eyob D. Adane et al.
PHARMACOTHERAPY (2015)
Vancomycin Pharmacokinetic and Pharmacodynamic Models for Critically Ill Patients with Post-Sternotomy Mediastinitis
Olivier Mangin et al.
CLINICAL PHARMACOKINETICS (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
Andrew A. Udy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Serum Cystatin C Is a Major Predictor of Vancomycin Clearance in a Population Pharmacokinetic Analysis of Patients with Normal Serum Creatinine Concentrations
Jae-Yong Chung et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2013)
Vancomycin A Review of Population Pharmacokinetic Analyses
Amelie Marsot et al.
CLINICAL PHARMACOKINETICS (2012)
Population Pharmacokinetics of Vancomycin in Thai Patients
Tunggul Adi Purwonugroho et al.
SCIENTIFIC WORLD JOURNAL (2012)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens
Jason A. Roberts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population pharmacokinetics of vancomycin in adult and geriatric patients: comparison of eleven approaches
J.L. Sánchez et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Population Pharmacokinetic Analysis of Vancomycin Using Serum Cystatin C as a Marker of Renal Function
Akihiro Tanaka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation
Natalia Revilla et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Vancomycin pharmacokinetics in patients with severe burn injuries
Michael Dolton et al.
BURNS (2010)
Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations
A. H. Thomson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models:: The npde add-on package for R
Emmanuelle Comets et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2008)
Share Paper
